During the forecast period, incident cases of malignant melanoma of the skin will continue to increase across the seven major markets. This increase will be due to a combination of increasing incidence rates and population growth and will be strongest in the US and the five major EU markets. Malignant melanoma is rare in Japan and will increase more slowly over the forecast period.
Features and benefits
Highlights
The World Health Organization has reported that the incidence of malignant melanoma is increasing faster than any other cancer in the world. Amount of and susceptibility to ultraviolet exposure are the key risk factors for malignant melanoma and are driving the increase in incidence in all age groups.
Datamonitor estimates that 125,700 people were diagnosed with malignant melanoma in the seven major markets in 2011. Age-specific incidence rates will increase uniformly between 2011 and 2021. Combined with growing populations, this will cause a 35% increase during the forecast period, bringing the number of incident cases to 170,200 in 2021.
Buy your copy of this report @ http://www.reportsnreports.com/reports/165051-epidemiology-malignant-melanoma-increasing-by-roughly-3-annually-and-affecting-all-age-groups.html
Report Details:
Published: April 2012
No. of Pages: 31
Price: Single User License: US$5700 Corporate User License: US$14250
Table Of contents
OVERVIEW
Catalyst
Summary
EXECUTIVE SUMMARY
Malignant melanoma epidemiology
Malignant melanoma forecast
DISEASE DEFINITION AND DIAGNOSTIC CRITERIA
Module scope
GLOBAL VARIATION AND HISTORICAL TRENDS
Steady increases in malignant melanoma incidence since the 1970s
Malignant melanoma incidence varies by latitude
DRIVERS OF MALIGNANT MELANOMA EPIDEMIOLOGY
Outdoor exposure to ultraviolet light is undoubtedly associated with malignant melanoma
Indoor tanning increasing in popularity and probably a risk factor for malignant melanoma
Light skin color and nevus presence associated with increased malignant melanoma incidence
EPIDEMIOLOGIC FORECASTING OF MALIGNANT MELANOMA
Overview
Subpopulations
Age
Stage
BRAF mutation
Analysis of the seven major markets
Sources used
Methods
EPIDEMIOLOGIC RESULTS
Estimated incident cases
Segmentation of incident cases by age and gender
Segmentation of incident cases by stage
Segmentation of incident cases by BRAF mutation
Age-standardized rates
DISCUSSION
Growth in melanoma incidence has been steady for 4 decades and is continuing
Strengths and limitations of Datamonitor’s epidemiologic projections
BIBLIOGRAPHY
Journal papers
Websites
APPENDIX
Module methodology
List Of Tables
Table: Cancer registry data sources for the seven major markets
Table: Incident cases of malignant melanoma in the seven major markets, 2011–21
Table: Incident cases of malignant melanoma in the seven major markets, by age, 2011
Table: Incident cases of malignant melanoma in the seven major markets, by stage, 2011
Table: Incident cases of malignant melanoma in the seven major markets, by BRAF mutation, 2011
Features and benefits
- Gain insight into market potential including a robust 10-year epidemiology forecast of malignant melanoma incident cases.
- Understand the key epidemiologic risk factors associated with malignant melanoma.
Highlights
The World Health Organization has reported that the incidence of malignant melanoma is increasing faster than any other cancer in the world. Amount of and susceptibility to ultraviolet exposure are the key risk factors for malignant melanoma and are driving the increase in incidence in all age groups.
Datamonitor estimates that 125,700 people were diagnosed with malignant melanoma in the seven major markets in 2011. Age-specific incidence rates will increase uniformly between 2011 and 2021. Combined with growing populations, this will cause a 35% increase during the forecast period, bringing the number of incident cases to 170,200 in 2021.
Buy your copy of this report @ http://www.reportsnreports.com/reports/165051-epidemiology-malignant-melanoma-increasing-by-roughly-3-annually-and-affecting-all-age-groups.html
Report Details:
Published: April 2012
No. of Pages: 31
Price: Single User License: US$5700 Corporate User License: US$14250
Table Of contents
OVERVIEW
Catalyst
Summary
EXECUTIVE SUMMARY
Malignant melanoma epidemiology
Malignant melanoma forecast
DISEASE DEFINITION AND DIAGNOSTIC CRITERIA
Module scope
GLOBAL VARIATION AND HISTORICAL TRENDS
Steady increases in malignant melanoma incidence since the 1970s
Malignant melanoma incidence varies by latitude
DRIVERS OF MALIGNANT MELANOMA EPIDEMIOLOGY
Outdoor exposure to ultraviolet light is undoubtedly associated with malignant melanoma
Indoor tanning increasing in popularity and probably a risk factor for malignant melanoma
Light skin color and nevus presence associated with increased malignant melanoma incidence
EPIDEMIOLOGIC FORECASTING OF MALIGNANT MELANOMA
Overview
Subpopulations
Age
Stage
BRAF mutation
Analysis of the seven major markets
Sources used
Methods
EPIDEMIOLOGIC RESULTS
Estimated incident cases
Segmentation of incident cases by age and gender
Segmentation of incident cases by stage
Segmentation of incident cases by BRAF mutation
Age-standardized rates
DISCUSSION
Growth in melanoma incidence has been steady for 4 decades and is continuing
Strengths and limitations of Datamonitor’s epidemiologic projections
BIBLIOGRAPHY
Journal papers
Websites
APPENDIX
Module methodology
List Of Tables
Table: Cancer registry data sources for the seven major markets
Table: Incident cases of malignant melanoma in the seven major markets, 2011–21
Table: Incident cases of malignant melanoma in the seven major markets, by age, 2011
Table: Incident cases of malignant melanoma in the seven major markets, by stage, 2011
Table: Incident cases of malignant melanoma in the seven major markets, by BRAF mutation, 2011